NexGel Retained Earnings (Accumulated Deficit) 2021-2024 | NXGL
NexGel retained earnings (accumulated deficit) from 2021 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| NexGel Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-18 |
| 2023 | $-15 |
| 2022 | $-12 |
| 2021 | $-7 |
| 2020 | $-3 |
| NexGel Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-18 |
| 2024-09-30 | $-17 |
| 2024-06-30 | $-16 |
| 2024-03-31 | $-16 |
| 2023-12-31 | $-15 |
| 2023-09-30 | $-14 |
| 2023-06-30 | $-13 |
| 2023-03-31 | $-12 |
| 2022-12-31 | $-12 |
| 2022-09-30 | $-11 |
| 2022-06-30 | $-10 |
| 2022-03-31 | $-9 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-3 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.020B | $0.009B |
| NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa. | |||